Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 5Lymphoma 4Neuroblastoma 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1Adenocarcinoma of Lung 1

Interventions

Methotrexate 7Cyclophosphamide 7Methylprednisolone 6merphos 5Cytarabine 5Asparaginase 5pegaspargase 4Vincristine 4Specimen Handling 4Mercaptopurine 4Leucovorin 4Dexamethasone 4Daunorubicin 4dexamethasone acetate 3dexamethasone 21-phosphate 3calaspargase pegol 3azathiopurine 3auricularum 3Thioguanine 3Prednisolone 3Hydrocortisone 3Etoposide 3Doxorubicin 3Calcium Dobesilate 3Antilymphocyte Serum 3prednylidene 2liposomal amphotericin B 2exifone 2deltacortene 2blinatumomab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Biphenotypic, Acute × Vindesine × Clear all
NCT00003728 2011-01-21

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,500 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡